1. Home
  2. CTSH vs NTRA Comparison

CTSH vs NTRA Comparison

Compare CTSH & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cognizant Technology Solutions Corporation

CTSH

Cognizant Technology Solutions Corporation

HOLD

Current Price

$82.06

Market Cap

40.6B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$230.96

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSH
NTRA
Founded
1994
2003
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6B
32.9B
IPO Year
1998
2015

Fundamental Metrics

Financial Performance
Metric
CTSH
NTRA
Price
$82.06
$230.96
Analyst Decision
Buy
Strong Buy
Analyst Count
17
15
Target Price
$88.87
$249.53
AVG Volume (30 Days)
4.5M
1.1M
Earning Date
02-04-2026
02-26-2026
Dividend Yield
1.50%
N/A
EPS Growth
N/A
N/A
EPS
4.32
N/A
Revenue
$20,857,000,000.00
$2,116,676,000.00
Revenue This Year
$8.99
$33.77
Revenue Next Year
$4.66
$16.92
P/E Ratio
$19.08
N/A
Revenue Growth
7.44
38.17
52 Week Low
$65.15
$125.38
52 Week High
$90.82
$256.36

Technical Indicators

Market Signals
Indicator
CTSH
NTRA
Relative Strength Index (RSI) 43.98 44.72
Support Level $84.14 $229.14
Resistance Level $85.93 $250.00
Average True Range (ATR) 1.83 8.27
MACD -0.50 -1.38
Stochastic Oscillator 8.48 21.29

Price Performance

Historical Comparison
CTSH
NTRA

About CTSH Cognizant Technology Solutions Corporation

Cognizant Technology Solutions is a multinational IT services provider that offers a range of consulting and business process outsourcing services. Originally founded in India, the company is headquartered in the US and serves enterprise customers spanning the financial services, healthcare, and resources industries. With most of its workforce located in India, Cognizant leverages a global delivery model that helps clients outsource their IT needs to offshore labor.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: